Financhill
Buy
67

EMR Quote, Financials, Valuation and Earnings

Last price:
$135.51
Seasonality move :
2.32%
Day range:
$134.40 - $136.17
52-week range:
$90.06 - $150.27
Dividend yield:
1.58%
P/E ratio:
33.49x
P/S ratio:
4.26x
P/B ratio:
3.75x
Volume:
1.8M
Avg. volume:
2.5M
1-year change:
9.33%
Market cap:
$76.1B
Revenue:
$18B
EPS (TTM):
$4.05

Earnings Data

Next earnings date for EMR
Feb 04
2026
Most recent earnings per share
$1.13
Missed by $0.49
(Nov 5/2025)
Consensus Estimate
$1.62
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EMR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $4.4B -- -- $1.42 --
11/05/2025 Q3 $4.9B $4.9B $1.13 $1.62 -$0.49
08/06/2025 Q2 $4.6B $4.6B $1.04 $1.51 -$0.47
05/07/2025 Q1 $4.4B $4.4B $0.86 $1.41 -$0.56
02/05/2025 Q4 $4.2B $4.2B $1.02 $1.28 -$0.25
11/05/2024 Q3 $4.6B $4.6B $1.74 $1.47 $0.27
08/07/2024 Q2 $4.4B $4.4B $0.57 $1.41 -$0.84
05/08/2024 Q1 $4.3B $4.4B $0.87 $1.25 -$0.38
02/07/2024 Q4 $3.9B $4.1B $0.25 $1.04 -$0.79
11/07/2023 Q3 -- $4.1B $1.22 -- --
08/02/2023 Q2 -- $3.9B $1.12 -- --
05/03/2023 Q1 -- $3.8B $0.92 -- --
02/08/2023 Q4 -- $3.4B $0.56 -- --
11/02/2022 Q3 -- $3.9B $0.82 -- --
08/09/2022 Q2 -- $3.5B $0.38 -- --
05/04/2022 Q1 -- $3.3B $0.72 -- --
02/02/2022 Q4 -- $3.2B $1.25 -- --
11/03/2021 Q3 -- $4.9B $1.12 -- --
08/04/2021 Q2 -- $4.7B $1.04 -- --
05/05/2021 Q1 -- $4.4B $0.93 -- --
02/02/2021 Q4 -- $4.2B $0.74 -- --
11/03/2020 Q3 -- $4.6B $1.20 -- --
08/04/2020 Q2 -- $3.9B $0.67 -- --
04/21/2020 Q1 -- $4.2B $0.85 -- --
02/04/2020 Q4 -- $4.2B $0.53 -- --
11/05/2019 Q3 -- $5B $1.16 -- --
08/06/2019 Q2 -- $4.7B $0.97 -- --
05/07/2019 Q1 -- $4.6B $0.84 -- --
02/05/2019 Q4 -- $4.1B $0.74 -- --
11/06/2018 Q3 -- $4.9B $0.98 -- --
08/07/2018 Q2 -- $4.5B $1.12 -- --
05/01/2018 Q1 -- $4.2B $0.76 -- --
02/06/2018 Q4 -- $3.8B $0.61 -- --
11/07/2017 Q3 -- $4.4B $0.79 -- --
08/01/2017 Q2 -- $4B $0.62 -- --
05/02/2017 Q1 -- $3.6B $0.43 -- --
02/07/2017 Q4 -- $3.2B $0.35 -- --
11/01/2016 Q3 -- $3.9B $0.68 -- --
08/02/2016 Q2 -- $3.7B $0.74 -- --
05/03/2016 Q1 -- $3.6B $0.57 -- --
02/02/2016 Q4 -- $3.3B $0.53 -- --

Emerson Electric Co. Earnings Questions

  • How Much did Emerson Electric Co. Generate in Revenue Last Quarter?

    Emerson Electric Co. reported $4.9B worth of top line sales in its most recent quarter.

  • Did Emerson Electric Co. Beat Earnings Last Quarter?

    Emerson Electric Co. announced earnings per share of $1.13 which represents a miss of analyst forecast a $1.62 per share.

  • Is Emerson Electric Co. Profitable?

    Emerson Electric Co. reported $2.3B that represents $4.09 per share over the last quarter.

  • What is the Analyst Consensus for Emerson Electric Co. EPS Next Year?

    Emerson Electric Co.'s earnings are forecast to grow from $4.05 per share to $6.00 per share next year representing an increase of 59.83%.

  • When is Emerson Electric Co.'s Earnings Date?

    Emerson Electric Co.'s next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock